Author: Kai Duan; Bende Liu; Cesheng Li; Huajun Zhang; Ting Yu; Jieming Qu; Min Zhou; Li Chen; Shengli Meng; Yong Hu; Cheng Peng; Mingchao Yuan; Jinyan Huang; Zejun Wang; Jianhong Yu; Xiaoxiao Gao; Dan Wang; Xiaoqi Yu; Li Li; Jiayou Zhang; Xiao Wu; Bei Li; Yanping Yu; Wei Chen; Yan Peng; Yeqin Hu; Lianzhen Lin; Xuefei Liu; Shihe Huang; Zhijun Zhou; Lianghao Zhang; Yue Wang; Zhi Zhang; Kun Deng; Zhiwu Xia; Qin Gong; Wei Zhang; Xiaobei Zheng; Ying Liu; Huichuan Yang; Dongbo Zhou; Ding Yu; Jifeng Hou; Zhengli Shi; Saijuan Chen; Zhu Chen; Xin-xin Zhang; Xiaoming Yang
Title: The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study Document date: 2020_3_23
ID: 8znnq0rh_34
Snippet: The second key factor associated with efficacy is the treatment time point. A better treatment outcome was observed among SARS patients who were given CP before 14 dpoi (58.3% vs 15.6%; P < 0.01), highlighting the importance of timely rescue therapy (9) . The mean time from onset of illness to CP transfusion was 16.5 days. Consistent with previous research, all three patients All rights reserved. No reuse allowed without permission......
Document: The second key factor associated with efficacy is the treatment time point. A better treatment outcome was observed among SARS patients who were given CP before 14 dpoi (58.3% vs 15.6%; P < 0.01), highlighting the importance of timely rescue therapy (9) . The mean time from onset of illness to CP transfusion was 16.5 days. Consistent with previous research, all three patients All rights reserved. No reuse allowed without permission.
Search related documents:
Co phrase search for related documents- key factor and mean time: 1, 2, 3, 4
- key factor and previous research: 1, 2, 3
- key factor and SARS patient: 1, 2
- key factor and treatment outcome: 1, 2, 3, 4
- key factor and treatment time: 1, 2
- mean time and previous research: 1
- mean time and rescue therapy: 1, 2, 3, 4
- mean time and SARS patient: 1, 2, 3, 4, 5, 6, 7
- mean time and treatment outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- mean time and treatment time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- mean time and treatment time point: 1, 2
- previous research and SARS patient: 1, 2
- previous research and treatment outcome: 1
- previous research and treatment time: 1, 2
- rescue therapy and SARS patient: 1
- rescue therapy and treatment outcome: 1, 2, 3, 4, 5, 6
- rescue therapy and treatment time: 1, 2, 3
- SARS patient and treatment outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9
- SARS patient and treatment time: 1, 2, 3, 4, 5, 6, 7, 8
Co phrase search for related documents, hyperlinks ordered by date